Related Experiment Video
Updated: Jul 31, 2025
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Cardiopulmonary outcomes following high flow nasal cannula in pediatric population: A systematic review
Rakan A Alrzoq1, Osama M Alateeq2, Maha S Almslam3
1Department of Pediatrics, King Faisal Specialist Hospital and Research Centre, Al Takhassousi & 12713, Riyadh 11211, Saudi Arabia.
Insights
High-flow nasal cannula (HFNC) therapy improves oxygen saturation and vital signs in pediatric cardiac patients. Evidence supports HFNC over other oxygenation methods for children with heart conditions.
Area of Science:
- Pediatric Cardiology
- Respiratory Therapy
- Critical Care Medicine
Background:
- High-flow nasal cannula (HFNC) therapy is increasingly utilized in diverse clinical settings.
- HFNC has recently gained approval for pediatric use, prompting further investigation.
Conclusions:
- HFNC therapy effectively reduces anatomical dead space and normalizes key cardiopulmonary parameters.
- Current evidence supports HFNC as a superior oxygenation treatment for pediatric cardiac patients compared to traditional methods.
Background:
The high-flow nasal cannula (HFNC) has received much attention in various clinical settings and has been approved recently for application in pediatric care.
Objectives:
To determine whether HFNC use improves cardiopulmonary outcomes in pediatric patients with the cardiac disease more effectively than alternative oxygen therapies.
Methods:
Systematic review was performed using PubMed, Scopus, and Web of Science databases. Randomized controlled trials comparing HFNC with alternative oxygen therapies and observational studies that solely reported on the use of HFNC in the pediatric population were included between 2012 and 2022.
Results:
Nine studies with approximately 656 patients were reported in this review. HFNC significantly increased systemic oxygen saturation across all literature investigating this parameter. Other notable outcomes in HFNC patients included normalizing heart rate, partial blood pressure, and PaO2/FiO2 ratio. However, some studies reported a complication rate concurrent with traditional oxygen therapies, and a suggested HFNC failure rate of 50% was observed.
Conclusions:
Compared with traditional oxygen therapies, HFNC can reduce anatomical dead space and normalize systemic oxygen saturation, PaO2/FiO2 ratio, heart rate, and partial blood pressure. We advocate using HFNC therapy in children with cardiac diseases as the currently available evidence supports HFNC use over other oxygenation treatments in the pediatric population.
Related Concept Videos
01:29Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
01:26Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
01:22Cardiopulmonary Resuscitation II: ACLS Airway Management
01:29Suctioning the Nasopharyngeal Airway
Equipment Required
01:19Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
01:23Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...